Analysen von Michael Leuchten

06.03.20 Merck Neutral UBS AG
03.03.20 Bayer buy UBS AG
27.02.20 Bayer buy UBS AG
18.02.20 AstraZeneca Sell UBS AG
07.02.20 Roche buy UBS AG
06.02.20 Novo Nordisk Neutral UBS AG
03.02.20 AstraZeneca Sell UBS AG
30.01.20 Roche buy UBS AG
17.01.20 Novo Nordisk Neutral UBS AG
10.01.20 Roche buy UBS AG
12.12.19 AstraZeneca Sell UBS AG
09.12.19 AstraZeneca Sell UBS AG
09.12.19 Sartorius vz. Neutral UBS AG
06.12.19 Novo Nordisk Neutral UBS AG
03.12.19 AstraZeneca Sell UBS AG
26.11.19 Merck Neutral UBS AG
25.11.19 Roche buy UBS AG
21.11.19 Novo Nordisk Neutral UBS AG
19.11.19 Bayer buy UBS AG
18.11.19 Novo Nordisk Neutral UBS AG
14.11.19 Roche buy UBS AG
14.11.19 Merck Neutral UBS AG
11.11.19 Roche buy UBS AG
11.11.19 AstraZeneca Sell UBS AG
07.11.19 Roche buy UBS AG
01.11.19 Novo Nordisk buy UBS AG
31.10.19 Bayer buy UBS AG
30.10.19 Bayer buy UBS AG
29.10.19 AstraZeneca Sell UBS AG
24.10.19 AstraZeneca Sell UBS AG
21.10.19 Novo Nordisk buy UBS AG
21.10.19 Sartorius vz. Neutral UBS AG
16.10.19 Roche buy UBS AG
17.09.19 Roche buy UBS AG
16.09.19 Roche buy UBS AG
10.09.19 AstraZeneca Sell UBS AG
05.09.19 Bayer buy UBS AG
02.09.19 Novo Nordisk buy UBS AG
09.08.19 Novo Nordisk buy UBS AG
08.08.19 Merck Neutral UBS AG
31.07.19 Bayer buy UBS AG
31.07.19 Novo Nordisk buy UBS AG
30.07.19 Bayer buy UBS AG
26.07.19 Roche buy UBS AG
25.07.19 AstraZeneca Sell UBS AG
25.07.19 Roche Neutral UBS AG
19.07.19 Sartorius vz. Neutral UBS AG
16.07.19 Bayer buy UBS AG
02.07.19 Sartorius vz. Neutral UBS AG
28.06.19 Bayer buy UBS AG